Intravenous antihypertensive drugs: a double-edged sword?

J Hypertens. 2023 Feb 1;41(2):220-222. doi: 10.1097/HJH.0000000000003344.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Administration, Intravenous
  • Antihypertensive Agents* / adverse effects
  • Humans

Substances

  • Antihypertensive Agents